Filter Results:
(9,919)
Show Results For
- All HBS Web
(9,919)
- People (25)
- News (1,506)
- Research (7,104)
- Events (19)
- Multimedia (16)
- Faculty Publications (5,535)
Show Results For
- All HBS Web
(9,919)
- People (25)
- News (1,506)
- Research (7,104)
- Events (19)
- Multimedia (16)
- Faculty Publications (5,535)
- 2017
- Working Paper
Innovation, Reallocation and Growth
By: Daron Acemoglu, Ufuk Akcigit, Harun Alp, Nicholas Bloom and William R. Kerr
We build a model of firm-level innovation, productivity growth, and reallocation featuring endogenous entry and exit. A new and central economic force is the selection between high- and low-type firms, which differ in terms of their innovative capacity. We estimate the... View Details
Keywords: Entry; Growth; Industrial Policy; Innovation; R＆D; Reallocation; Selection; Business Ventures; Resource Allocation; Performance Productivity; Policy; Research and Development; Innovation and Invention; Growth and Development; United States
Acemoglu, Daron, Ufuk Akcigit, Harun Alp, Nicholas Bloom, and William R. Kerr. "Innovation, Reallocation and Growth." Harvard Business School Working Paper, No. 13-088, April 2013. (Revised November 2017. NBER Working Paper Series, No. 18993, April 2013)
- 2001
- Working Paper
The Disruptive Roots of National Economic Growth and Development
By: Clayton M. Christensen, Stuart Hart and Thomas Craig
- 1996
- Chapter
Eli Lilly and Company: Drug Development Strategy
By: S. Thomke, A. Nimgade and P. Pospisil
- June 2003
- Teaching Note
Endeavor--Determining A Growth Strategy (TN)
Teaching Note for (9-803-126). View Details
- 04 Oct 2022
- News
Corporate Governance and Growth Strategy at Capital SAFI
- October 1997 (Revised September 2003)
- Case
Eli Lilly and Company: Drug Development Strategy (A)
By: Stefan H. Thomke, Ashok Nimgade and Paul Pospisil
Describes how Eli Lilly and Co. tries to accelerate its new drug development process with the aid of "combinatorial chemistry"--a rapidly emerging and revolutionary approach to preclinical drug discovery. The product manager of a potential blockbuster migraine drug... View Details
Keywords: Chemicals; Finance; Innovation and Invention; Time Management; Markets; Product Development; Organizations; Business Processes; Problems and Challenges; Business and Stakeholder Relations; Competition; Pharmaceutical Industry
Thomke, Stefan H., Ashok Nimgade, and Paul Pospisil. "Eli Lilly and Company: Drug Development Strategy (A)." Harvard Business School Case 698-010, October 1997. (Revised September 2003.)
- June 2012 (Revised December 2017)
- Technical Note
Strategy and Strategic Decisions
This note introduces a framework for formulating strategy that helps a manager identify which decisions are strategic—and thus which decisions to focus on (both when developing strategy and when executing it)—and that provides a practical test for whether a particular... View Details
Keywords: Formulating Strategy; Strategic Theory; Strategy Test; Strategic Analysis; Strategy; Theory; Strategic Planning
Van den Steen, Eric. "Strategy and Strategic Decisions." Harvard Business School Technical Note 712-500, June 2012. (Revised December 2017.)
- 2000
- Working Paper
The Process of Strategy Development and Implementation
By: Clayton M. Christensen and Tara Donovan
- 04 Oct 2022
- Cold Call Podcast
Cold Call: Corporate Governance and Growth Strategy at Capital SAFI
- March 2014
- Case
Inequality and Growth in the 'Chinese Dream'
By: Rafael Di Tella, Meg Rithmire and Kaitlyn Szydlowski
Xi Jinping assumed his position as head of China's fifth generation of leaders in 2012. Xi was head of both the People's Republic of China and the Chinese Communist Party, which had ruled China since 1949. Xi inherited a country far more unequal than the one that Mao... View Details
- February 1990
- Article
Developing the Competitive Organization: Interventions and Strategies
By: M. Beer
Beer, M. "Developing the Competitive Organization: Interventions and Strategies." American Psychologist 45, no. 2 (February 1990): 154–161.
- 2016
- Working Paper
Notes on Developing a Strategy and Designing a Company
By: Kevin J. Boudreau
The practice and teaching of business strategy today exist largely as a set of alternative views and frameworks not entirely connected to one another. These notes contribute an integrated sequence of steps for creating or evaluating a strategy and associated company... View Details
Keywords: Business Strategy
Boudreau, Kevin J. "Notes on Developing a Strategy and Designing a Company." Harvard Business School Working Paper, No. 16-131, May 2016. (Revised June 2016.)
- 01 Feb 2013
- News
Growth Strategy Has Double Bottom Line
generates returns for investors through timber harvesting, recreational leasing, and in some cases, by subdividing the properties for development or non-timber uses. Lyme Timber, however, is unique among... View Details
- March 2009 (Revised August 2010)
- Case
The Posse Foundation: Implementing a Growth Strategy
The Posse Foundation selected high-potential, non-traditional students to attend selective colleges as part of a group of 10 from the same city. The organization had developed an ambitious growth plan, but because it focused on the most selective colleges, the pool of... View Details
Keywords: Diversity; Higher Education; Social Entrepreneurship; Growth and Development Strategy; Corporate Social Responsibility and Impact; Personal Development and Career; Partners and Partnerships; Nonprofit Organizations; Education Industry
Childress, Stacey M., and Andrea Michelle Alexander. "The Posse Foundation: Implementing a Growth Strategy." Harvard Business School Case 309-056, March 2009. (Revised August 2010.)
- October 2001 (Revised March 2002)
- Case
Siemens AG: Global Development Strategy (A)
By: Stefan H. Thomke and Ashok Nimgade
Describes how Siemens, the German electrical engineering giant, has developed and manages global R&D in its large Information and Communications Networks (ICN) division. In 1994, Siemens opened its Bangalore (India) center, which has now grown into one of its largest... View Details
Keywords: Global Strategy; Research and Development; Cross-Cultural and Cross-Border Issues; Product Development; Telecommunications Industry; Germany; Bangalore
Thomke, Stefan H., and Ashok Nimgade. "Siemens AG: Global Development Strategy (A)." Harvard Business School Case 602-061, October 2001. (Revised March 2002.)
- 2011
- Case
CSCEC: Transformation and Development
By: F. Warren McFarlan, Donghong Li and Hong Zhang
In 2001, CSCEC, the largest residential building constructor in China, greeted its new General Manager, Wenjie Sun, who was the President of China Overseas, a Hong Kong-listed subsidiary of CSCEC. In the following 9 years, Sun strived to advance the transformation and... View Details
McFarlan, F. Warren, Donghong Li, and Hong Zhang. "CSCEC: Transformation and Development." Tsinghua University Case, 2011.
- May 2016 (Revised September 2017)
- Case
Pal's Sudden Service—Scaling an Organizational Model to Drive Growth
By: Gary P. Pisano, Francesca Gino and Bradley R. Staats
Pal's Sudden Service has developed a unique operating model and organizational culture in the quick service restaurant business. With a deep emphasis on process control and improvement, zero defects, extensive training, and a high level of employee engagement, Pal's... View Details
Keywords: Growth Strategy; Corporate Culture; Operations Strategy; Motivation; Values; Motivation and Incentives; Strategy; Values and Beliefs; Service Operations; Organizational Culture; Growth and Development Strategy; Food and Beverage Industry; Food and Beverage Industry
Pisano, Gary P., Francesca Gino, and Bradley R. Staats. "Pal's Sudden Service—Scaling an Organizational Model to Drive Growth." Harvard Business School Case 916-052, May 2016. (Revised September 2017.)
- May 2021
- Article
Private and Social Returns to R&D: Drug Development and Demographics
By: Efraim Benmelech, Janice Eberly, Dimitris Papanikolaou and Joshua Krieger
Investment in intangible capital such as R&D has increased dramatically since the 1990s. However, productivity growth remains sluggish in recent years. One potential reason is that a significant share of the increase in intangible investment is geared toward consumer... View Details
Keywords: Drug Development; Research and Development; Investment Return; Demographics; Pharmaceutical Industry
Benmelech, Efraim, Janice Eberly, Dimitris Papanikolaou, and Joshua Krieger. "Private and Social Returns to R&D: Drug Development and Demographics." AEA Papers and Proceedings 111 (May 2021): 336–340.
- October 2008
- Background Note
The Concept of Development Strategy
By: Gary P. Pisano
Pisano, Gary P. "The Concept of Development Strategy." Harvard Business School Background Note 609-045, October 2008.
- December 1997 (Revised September 2002)
- Supplement
Eli Lilly and Company: Drug Development Strategy (B)
By: Stefan H. Thomke and Ashok Nimgade
Supplements the (A) case. View Details
Thomke, Stefan H., and Ashok Nimgade. "Eli Lilly and Company: Drug Development Strategy (B)." Harvard Business School Supplement 698-026, December 1997. (Revised September 2002.)